ArticlePharmacology research & perspectives2025
A Comparative Analysis of Cardiovascular Events Associated With Acalabrutinib Versus Ibrutinib in Chronic Lymphocytic Leukemia: Insights From a Global Federated Network.
Abdulrahman Majrashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.